Both in Pharmaceuticals
Actinium Pharmaceuticals vs Biomea Fusion
Over the past year ATNM returned +1.4% and BMEA returned −52.7%; their daily moves had a correlation of 0.03.
ATNM +1.4% BMEA −52.7%Growth of $1, one year, split-adjusted
| Metric | ATNM | BMEA |
|---|---|---|
| Price | $1.40 | $0.6238 |
| Market cap | $44.0M | $45.2M |
| Today | −2.10% | −5.47% |
| 1 month | +16.7% | −52.0% |
| 6 months | +11.1% | −59.0% |
| Year to date | +2.9% | −49.7% |
| 1 year | −2.1% | −54.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | 79.7% | — |
| P/E (TTM) | 3.9× | — |
| Price / sales | 1.3× | — |
| Net cash | $36.5M | $34.8M |
| Dividend yield | — | — |
| Volatility (60d) | 90.6% | 122.1% |
| Short % of float | 2.0% | 24.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).